Search: onr:"swepub:oai:DiVA.org:uu-518359" >
In vitro anti-cance...
-
Paudel, Keshav RajCentenary Inst, Ctr Inflammat, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia.
(author)
In vitro anti-cancer activity of a polyherbal preparation, VEDICINALS®9, against A549 human lung adenocarcinoma cells
- Article/chapterEnglish2023
Publisher, publication year, extent ...
-
Elsevier,2023
-
printrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:uu-518359
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-518359URI
-
https://doi.org/10.1016/j.prp.2023.154832DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
PurposeNon-small cell lung cancer (NSCLC) is among the leading causes of morbidity and mortality worldwide. Despite the availability of several treatment options, the five-year survival rate of NSCLC is extremely low (<20%). This underlines the necessity of more effective therapeutic alternatives. In this context, plant-derived extracts and bioactive molecules extracted from plants, known collectively as phytoceuticals, represent an extremely variegated source of bioactive compounds with potent anticancer potential. In the present study, we tested the in vitro anticancer activity of a polyherbal preparation, VEDICINALS®9, containing nine different bioactive principles extracted by medicinal plants.MethodsThe anticancer activity of VEDICINALS®9 was investigated by measuring its impact on A549 human NSCLC cell proliferation (MTT assay and trypan blue staining), migration (wound healing assay and transwell chamber assay) and by measuring the impact on the expression of cancer-related proteins (Human XL Oncology Protein Array).ResultsWe show that VEDICINALS®9 at a concentration of 0.2% v/v has potent anticancer effect, significantly inhibiting A549 cell proliferation and migration. Mechanistically, this was achieved by downregulating the expression of proteins involved in cancer cell proliferation (Axl, FGF basic, enolase 2, progranulin, survivin) and migration (Dkk-1, cathepsins B and D, BCL-x, amphiregulin, CapG, u-plasminogen activator). Furthermore, treatment with VEDICINALS®9 resulted in increased expression of the oncosuppressor protein p53 and of the angiogenesis inhibitor endostatin.ConclusionsTaken together, our results provide proof of principle of the potent anticancer activity of the polyherbal preparation VEDICINALS®9, highlighting its enormous potential as an alternative or adjuvant therapy for lung cancer.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Rajput, RashiUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.
(author)
-
De Rubis, GabrieleUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia.
(author)
-
Allam, Venkata Sita Rama RajuUppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi(Swepub:uu)venal651
(author)
-
Williams, Kylie AnneUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.
(author)
-
Singh, Sachin KumarUniv Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia.;Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, Punjab, India.
(author)
-
Gupta, GauravSuresh Gyan Vihar Univ, Sch Pharm, Jaipur, Rajasthan, India.;Saveetha Univ, Saveetha Inst Med & Tech Sci, Saveetha Med Coll, Ctr Global Hlth Res, Chennai, India.;Graph Era Hill Univ, Sch Pharm, Dehra Dun 248007, India.
(author)
-
Salunke, PrakashVedicinals India Pvt Ltd, Pune, Maharashtra, India.
(author)
-
Hansbro, Philip MichaelCentenary Inst, Ctr Inflammat, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia.
(author)
-
Gerlach, JoachimVedicinals India Pvt Ltd, Pune, Maharashtra, India.;Verbindungsstr 21, D-40764 Langenfeld, Germany.
(author)
-
Dua, KamalUniv Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Fac Hlth, Ultimo, NSW 2007, Australia.;POB 123, Broadway, NSW 2007, Australia.
(author)
-
Centenary Inst, Ctr Inflammat, Sydney, NSW 2007, Australia.;Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2007, Australia.Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Sydney, NSW 2007, Australia.
(creator_code:org_t)
Related titles
-
In:Pathology, Research and Practice: Elsevier2500344-03381618-0631
Internet link
Find in a library
To the university's database
- By the author/editor
-
Paudel, Keshav R ...
-
Rajput, Rashi
-
De Rubis, Gabrie ...
-
Allam, Venkata S ...
-
Williams, Kylie ...
-
Singh, Sachin Ku ...
-
show more...
-
Gupta, Gaurav
-
Salunke, Prakash
-
Hansbro, Philip ...
-
Gerlach, Joachim
-
Dua, Kamal
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Pathology, Resea ...
- By the university
-
Uppsala University